New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf ...
Americans Skip Overseas Travel as Stem Cell Therapy Arrives at 5 U.S. Locations Aventura, United States - July 5, 2026 ...
In many animal tissues, stem cells continually divide to create new cells that replace old or damaged ones. However, this ...
A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...
Texas A&M researchers found a way to make stem cells produce double the normal number of mitochondria using nanoflower particles. These energized stem cells then transfer their surplus “power packs” ...
Orca Bio’s donor-derived personalized cell therapy Tregzi has received the regulatory green light to reduce the risk of chronic graft-versus-host disease (GVHD) in patients undergoing allogeneic ...
Xenophagocytosis is a natural immune process that limits interspecies organ generation by eliminating living donor cells, ...
Explore how stem cell biology is advancing strategies to repair the injured nervous system and support regeneration following ...
Humans cannot fully heal spinal cord injuries. When the spinal cord is damaged, the body's immune system often spirals into chaos. This overwhelming inflammatory response creates permanent scar tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results